John W. Raff
Fondateur chez Dovuro Seeds Pty Ltd.
Profil
John W.
Raff is the founder of Dovuro Seeds Pty Ltd., Nutrihealth Pty Ltd.
He currently serves as a Non-Executive Director at Paranta Biosciences Ltd.
Previously, he served as Deputy Chairman at Starpharma Holdings Ltd.
from 2009 to 2011, Chairman at BioMelbourne Network, Director at Farmacule BioIndustries Pty Ltd., and General Manager at The Biomolecular Research Institute Ltd.
He holds a doctorate degree from the University of Melbourne, which he received in 1982.
Postes actifs de John W. Raff
| Sociétés | Poste | Début |
|---|---|---|
Dovuro Seeds Pty Ltd.
 Dovuro Seeds Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Dovuro Seeds Pty Ltd. is an Australian company that produces and wholesales canola seeds. The company is based in Horsham, Australia. The company was founded by John W. Raff. Dovuro Seeds was acquired by Nufarm Ltd. on April 26, 2006. | Fondateur | 05/01/2011 |
Nutrihealth Pty Ltd.
 Nutrihealth Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Nutrihealth Pty Ltd. is an Australian company that produces grains and agricultural products. The company was founded by John W. Raff. Nutrihealth was acquired by Nufarm Ltd. on April 26, 2006. | Fondateur | 05/01/2011 |
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Directeur/Membre du Conseil | - |
Anciens postes connus de John W. Raff
| Sociétés | Poste | Fin |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Président | 05/08/2009 |
| The Biomolecular Research Institute Ltd. | Corporate Officer/Principal | - |
| BioMelbourne Network | Président | - |
Farmacule BioIndustries Pty Ltd.
 Farmacule BioIndustries Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Farmacule BioIndustries Pty Ltd. Developed industrial and therapeutic proteins and biofuels. It engaged in developing molecular farming technology to produce proteins, biofuels and bioplastics in plants for various industrial, therapeutic and diagnostic applications. The company was founded in 2001 and was headquartered in Altona North, Australia. | Directeur/Membre du Conseil | - |
Formation de John W. Raff
| University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
Farmacule BioIndustries Pty Ltd.
Farmacule BioIndustries Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Farmacule BioIndustries Pty Ltd. Developed industrial and therapeutic proteins and biofuels. It engaged in developing molecular farming technology to produce proteins, biofuels and bioplastics in plants for various industrial, therapeutic and diagnostic applications. The company was founded in 2001 and was headquartered in Altona North, Australia. | Commercial Services |
Dovuro Seeds Pty Ltd.
Dovuro Seeds Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Dovuro Seeds Pty Ltd. is an Australian company that produces and wholesales canola seeds. The company is based in Horsham, Australia. The company was founded by John W. Raff. Dovuro Seeds was acquired by Nufarm Ltd. on April 26, 2006. | Process Industries |
Nutrihealth Pty Ltd.
Nutrihealth Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Nutrihealth Pty Ltd. is an Australian company that produces grains and agricultural products. The company was founded by John W. Raff. Nutrihealth was acquired by Nufarm Ltd. on April 26, 2006. | Process Industries |
| BioMelbourne Network | |
| The Biomolecular Research Institute Ltd. | |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Health Technology |
